Researcher.Life Logo

Melanoma Management : Impact Factor & More

eISSN: 2045-0893pISSN: 2045-0885
JournalOpen Access

Key Metrics

SNIP
0.01
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Melanoma Management

Melanoma Management Journal Specifications

Overview
Publisher FUTURE MEDICINE LTD
Language English
Frequency Quarterly
Article Processing ChargesUSD 1415
Publication Time13
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2014
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 13
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Melanoma Management ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Melanoma Management

Insurance, race, and socioeconomic disparities in systemic therapy receipt for melanoma in the United States: a systematic review.
  • 17 Feb 2026
  • Melanoma management
Targeted therapies and PARPi therapy response following ICI therapy failure in advanced melanoma: a case series
  • 9 Dec 2025
  • Melanoma Management
Personalized therapies in advanced BRAFV600-mutated melanoma: review based on 3 case reports of the REMINISCENCE project.
  • 1 Dec 2025
  • Melanoma management
Primary dermal melanoma: a rare subtype of cutaneous melanoma.
  • 1 Dec 2025
  • Melanoma management
Brain organoid technology in melanoma metastasis to the brain.
  • 27 Oct 2025
  • Melanoma management
Patient preferences for stages II–IV melanoma treatments in the UK: results from a cross-sectional study
  • 18 Oct 2025
  • Melanoma Management
Insurance, race, and socioeconomic disparities in systemic therapy receipt for melanoma in the United States: a systematic review.
  • 17 Feb 2026
  • Melanoma management
Targeted therapies and PARPi therapy response following ICI therapy failure in advanced melanoma: a case series
  • 9 Dec 2025
  • Melanoma Management
Personalized therapies in advanced BRAFV600-mutated melanoma: review based on 3 case reports of the REMINISCENCE project.
  • 1 Dec 2025
  • Melanoma management
Primary dermal melanoma: a rare subtype of cutaneous melanoma.
  • 1 Dec 2025
  • Melanoma management
Brain organoid technology in melanoma metastasis to the brain.
  • 27 Oct 2025
  • Melanoma management
Patient preferences for stages II–IV melanoma treatments in the UK: results from a cross-sectional study
  • 18 Oct 2025
  • Melanoma Management

FAQs on Melanoma Management